The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Oscar Health Inc shares valued at $11,551 were purchased by ALESSANDREA QUANE on Mar 10 ’25. At $16.50 per share, ALESSANDREA QUANE acquired 700 shares.
Also, ALESSANDREA QUANE purchased 5,101 shares, netting a total of over 84,181 in proceeds.
Before that, ALESSANDREA QUANE had added 20,000 shares to its account. In a trade valued at $325,654, the Officer bought Oscar Health Inc shares for $16.28 each.
As published in their initiating research note from Jefferies on December 10, 2024, Oscar Health Inc [OSCR] has been an Underperform and the price target has been revised to $12. Analysts at BofA Securities downgraded the stock from ‘”a Neutral”‘ to ‘”an Underperform”‘ outlook in a report released in early November. As of October 07, 2024, UBS has initiated its “Neutral” rating for OSCR. Earlier on June 26, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for OSCR stock.
Analyzing OSCR Stock Performance
During the last five days, there has been a drop of approximately -12.68%. Over the course of the year, Oscar Health Inc shares have jumped approximately 5.58%. Shares of the company reached a 52-week high of $17.56 on 01/24/25 and a 52-week low of $12.43 on 02/13/25. A 50-day SMA is recorded $15.17, while a 200-day SMA reached $16.89.
Support And Resistance Levels for Oscar Health Inc (OSCR)
According to the 24-hour chart, there is a support level at 13.62, which, if violated, would cause prices to drop to 13.06. In the upper region, resistance lies at 14.92. The next price resistance is at 15.66. RSI (Relative Strength Index) is 42.76 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.46, which suggests the price will decrease in the coming days. Percent R is at 71.51%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.